Published in Trop Med Int Health on July 01, 2002
The risk of malarial infections and disease in Papua New Guinean children. Am J Trop Med Hyg (2007) 2.72
Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells. J Infect Dis (2007) 1.79
A sub-microscopic gametocyte reservoir can sustain malaria transmission. PLoS One (2011) 1.67
Strain-specific humoral response to a polymorphic malaria vaccine. Infect Immun (2004) 1.18
Mobile phones and malaria: modeling human and parasite travel. Travel Med Infect Dis (2013) 1.17
Review: analysis of parasite and other skewed counts. Trop Med Int Health (2012) 1.03
Increased polyclonal immunoglobulin reactivity toward human and bacterial proteins is associated with clinical protection in human Plasmodium infection. Malar J (2005) 0.87
The Utility of Malaria Rapid Diagnostic Tests as a Tool in Enhanced Surveillance for Malaria Elimination in Vanuatu. PLoS One (2016) 0.80
Asymptomatic Plasmodium falciparum infections may not be shortened by acquired immunity. Malar J (2015) 0.79
Impact of combined intermittent preventive treatment of malaria and helminths on anaemia, sustained attention, and recall in Northern Ghanaian schoolchildren. Glob Health Action (2016) 0.75
Sub-Saharan Africa's mothers, newborns, and children: where and why do they die? PLoS Med (2010) 5.54
A research agenda to underpin malaria eradication. PLoS Med (2011) 5.34
Cause-specific mortality rates in sub-Saharan Africa and Bangladesh. Bull World Health Organ (2006) 4.12
Child survival gains in Tanzania: analysis of data from demographic and health surveys. Lancet (2008) 4.03
Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana. BMJ (2005) 3.87
Setting international standards for verbal autopsy. Bull World Health Organ (2007) 3.59
Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infect Dis (2002) 3.46
The way forward. Lancet (2007) 3.28
An outbreak of serotype 1 Streptococcus pneumoniae meningitis in northern Ghana with features that are characteristic of Neisseria meningitidis meningitis epidemics. J Infect Dis (2005) 3.25
Mapping malaria transmission in West and Central Africa. Trop Med Int Health (2006) 3.02
Ageing and adult health status in eight lower-income countries: the INDEPTH WHO-SAGE collaboration. Glob Health Action (2010) 2.94
In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up. Antimicrob Agents Chemother (2004) 2.77
Sub-Saharan Africa's mothers, newborns, and children: how many lives could be saved with targeted health interventions? PLoS Med (2010) 2.77
Epidemiology of malaria in the forest-savanna transitional zone of Ghana. Malar J (2009) 2.67
Profile of the Navrongo Health and Demographic Surveillance System. Int J Epidemiol (2012) 2.44
Malaria transmission dynamics at a site in northern Ghana proposed for testing malaria vaccines. Trop Med Int Health (2004) 2.28
Likely health outcomes for untreated acute febrile illness in the tropics in decision and economic models; a Delphi survey. PLoS One (2011) 2.24
The World Bank: false financial and statistical accounts and medical malpractice in malaria treatment. Lancet (2006) 2.22
Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial. PLoS One (2008) 2.19
Should data from demographic surveillance systems be made more widely available to researchers? PLoS Med (2008) 2.06
The epidemiology of malaria in Papua New Guinea. Trends Parasitol (2003) 2.03
Malaria-induced acquisition of antibodies to Plasmodium falciparum variant surface antigens. Infect Immun (2002) 2.00
Seasonal malaria attack rates in infants and young children in northern Ghana. Am J Trop Med Hyg (2002) 1.91
Comparison of PCR-RFLP and Genescan-based genotyping for analyzing infection dynamics of Plasmodium falciparum. Am J Trop Med Hyg (2006) 1.86
Rapid achievement of the child survival millennium development goal: evidence from the Navrongo experiment in Northern Ghana. Trop Med Int Health (2007) 1.83
Monitoring future impact on malaria burden in sub-saharan Africa. Am J Trop Med Hyg (2004) 1.80
Estimating the duration of Plasmodium falciparum infection from trials of indoor residual spraying. Am J Trop Med Hyg (2004) 1.71
Tackling malaria today. BMJ (2008) 1.70
An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria. PLoS One (2008) 1.68
Severe falciparum malaria in young children of the Kassena-Nankana district of northern Ghana. Malar J (2007) 1.67
Seasonal profiles of malaria infection, anaemia, and bednet use among age groups and communities in northern Ghana. Trop Med Int Health (2003) 1.67
A shared Asian origin of the triple-mutant dhfr allele in Plasmodium falciparum from sites across Africa. J Infect Dis (2007) 1.61
Host population persistence in the face of introduced vector-borne diseases: Hawaii amakihi and avian malaria. Proc Natl Acad Sci U S A (2005) 1.59
Editorial: north-south research collaborations: a move towards a true partnership? Trop Med Int Health (2005) 1.58
Impact of community management of fever (using antimalarials with or without antibiotics) on childhood mortality: a cluster-randomized controlled trial in Ghana. Am J Trop Med Hyg (2012) 1.58
Clonal waves of Neisseria colonisation and disease in the African meningitis belt: eight- year longitudinal study in northern Ghana. PLoS Med (2007) 1.56
Seeking consent to genetic and genomic research in a rural Ghanaian setting: a qualitative study of the MalariaGEN experience. BMC Med Ethics (2012) 1.55
Better health statistics are possible. Lancet (2006) 1.54
Health inequalities among older men and women in Africa and Asia: evidence from eight Health and Demographic Surveillance System sites in the INDEPTH WHO-SAGE Study. Glob Health Action (2010) 1.54
Evaluation and application of modularly assembled zinc-finger nucleases in zebrafish. Development (2011) 1.54
Molecular genotyping to distinguish between recrudescents and new infections in treatment trials of Plasmodium falciparum malaria conducted in Sub-Saharan Africa: adjustment of parasitological outcomes and assessment of genotyping effectiveness. Trop Med Int Health (2006) 1.50
Using data envelopment analysis to measure the extent of technical efficiency of public health centres in Ghana. BMC Int Health Hum Rights (2008) 1.50
ImmPort: disseminating data to the public for the future of immunology. Immunol Res (2014) 1.48
An open letter to the Executive Board of WHO. Lancet (2002) 1.39
Options for the delivery of intermittent preventive treatment for malaria to children: a community randomised trial. PLoS One (2009) 1.38
Genotypic diversity and drug susceptibility patterns among M. tuberculosis complex isolates from South-Western Ghana. PLoS One (2011) 1.31
A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum. Clin Infect Dis (2003) 1.28
Spatio-temporal malaria transmission patterns in Navrongo demographic surveillance site, northern Ghana. Malar J (2013) 1.27
Changing patterns of rotavirus genotypes in ghana: emergence of human rotavirus G9 as a major cause of diarrhea in children. J Clin Microbiol (2003) 1.23
Use of health professionals for delivery following the availability of free obstetric care in northern Ghana. Matern Child Health J (2007) 1.23
A point mutation in codon 76 of pfcrt of P. falciparum is positively selected for by Chloroquine treatment in Tanzania. Infect Genet Evol (2002) 1.21
Clonal groupings in serogroup X Neisseria meningitidis. Emerg Infect Dis (2002) 1.20
Stillbirths and early neonatal mortality in rural Northern Ghana. Trop Med Int Health (2011) 1.20
A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Ghana. Trop Med Int Health (2005) 1.20
Getting polio eradication back on track in Nigeria. N Engl J Med (2004) 1.20
Assessing malaria control in the Kassena-Nankana district of northern Ghana through repeated surveys using the RBM tools. Malar J (2007) 1.19
Strain-specific humoral response to a polymorphic malaria vaccine. Infect Immun (2004) 1.18
Misclassification of Plasmodium infections by conventional microscopy and the impact of remedial training on the proficiency of laboratory technicians in species identification. Malar J (2013) 1.18
Detectability of Plasmodium falciparum clones. Malar J (2010) 1.17
Molecular monitoring in malaria vaccine trials. Trends Parasitol (2003) 1.15
The added value of claims for cancer surveillance: results of varying case definitions. Med Care (2005) 1.14
Emergence of W135 meningococcal meningitis in Ghana. Trop Med Int Health (2005) 1.11
Adipose tissue n-6 fatty acids and acute myocardial infarction in a population consuming a diet high in polyunsaturated fatty acids. Am J Clin Nutr (2003) 1.10
A six year retrospective review of occipital nerve stimulation practice--controversies and challenges of an emerging technique for treating refractory headache syndromes. J Headache Pain (2013) 1.09
An immigration-death model to estimate the duration of malaria infection when detectability of the parasite is imperfect. Stat Med (2005) 1.09
Malaria epidemiology in the Ahafo area of Ghana. Malar J (2011) 1.08
Ownership and technical efficiency of hospitals: evidence from Ghana using data envelopment analysis. Cost Eff Resour Alloc (2014) 1.06
The impact of immunization on the association between poverty and child survival: evidence from Kassena-Nankana District of northern Ghana. Scand J Public Health (2009) 1.04
The distribution of Plasmodium falciparum infection durations. Epidemics (2011) 1.04
Placental malaria and the risk of malaria in infants in a high malaria transmission area in ghana: a prospective cohort study. J Infect Dis (2013) 1.03
Distinct Notch signaling outputs pattern the developing arterial system. Development (2014) 1.02
A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma. Clin Cancer Res (2004) 1.02
Doc, shouldn't we be getting some tests? J Clin Oncol (2003) 1.01
Endemic Burkitt lymphoma is associated with strength and diversity of Plasmodium falciparum malaria stage-specific antigen antibody response. Blood (2013) 1.01
Normal CD4+ T lymphocyte levels in HIV seronegative individuals in the Manya/Yilo Krobo communities in the Eastern region of Ghana. Viral Immunol (2006) 1.01
Age of menarche among basic level school girls in Medina, Accra. Afr J Reprod Health (2011) 0.99
Sero-epidemiology as a tool to screen populations for exposure to Mycobacterium ulcerans. PLoS Negl Trop Dis (2012) 0.98
African Burkitt lymphoma: age-specific risk and correlations with malaria biomarkers. Am J Trop Med Hyg (2011) 0.97
Understanding and retention of the informed consent process among parents in rural northern Ghana. BMC Med Ethics (2008) 0.96
Antigenic cross-reactivity between different alleles of the Plasmodium falciparum merozoite surface protein 2. Parasite Immunol (2004) 0.95
Multimorbidity of chronic diseases among adult patients presenting to an inner-city clinic in Ghana. Global Health (2013) 0.95
Artemether-lumefantrine: an oral antimalarial for uncomplicated malaria in children. Expert Rev Anti Infect Ther (2009) 0.94
Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana. Malar J (2012) 0.94
A community-wide study of malaria reduction: evaluating efficacy and user-acceptance of a low-cost repellent in northern Ghana. Am J Trop Med Hyg (2012) 0.94
Regenerative medicine as applied to general surgery. Ann Surg (2012) 0.92
Insecticide resistance profiles for malaria vectors in the Kassena-Nankana district of Ghana. Malar J (2009) 0.92
Effect of the malaria vaccine Combination B on merozoite surface antigen 2 diversity. Infect Genet Evol (2006) 0.92
Effects of rifampin and ketoconazole on the pharmacokinetics of nilotinib in healthy participants. J Clin Pharmacol (2010) 0.92
Characterisation of norovirus strains in rural Ghanaian children with acute diarrhoea. J Med Virol (2006) 0.92